Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Goepferich

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of Drug Targeting|May 8, 2015
Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticlesRobert Hennig, Klaus Pollinger, Joerg Tessmar, et al.
International Journal of Pharmaceutics|November 17, 2015
HPLC analysis as a tool for assessing targeted liposome compositionMira Oswald, Michael Platscher, Simon Geissler, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryMiriam Breunig, Uta Lungwitz, Renate Liebl, et al.
Macromolecular Bioscience|February 21, 2020
The Effect of Ligand Mobility on the Cellular Interaction of Multivalent NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
Pharmaceutical Research|February 26, 2020
Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
Journal of Drug Targeting|March 15, 2016
Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosisRobert Hennig, Sabrina Kuespert, Alexandra Haunberger, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 29, 2017
Polyanion based controlled release system for the GnRH-receptor antagonist degarelixMichael Backofen, Gregoire Schwach, Wolfgang Koechling, et al.
Drug Discovery Today|June 2, 2022
Targeted drug delivery to the retinal pigment epithelium: Untapped therapeutic potential for retinal diseasesMarilena Bohley, Andrea E Dillinger, Ernst R Tamm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 17, 2014
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylationRobert Hennig, Klaus Pollinger, Anika Veser, et al.
Journal of Pharmaceutical Sciences|July 29, 2010
Biocompatibility of an injectable in situ forming depot for peptide deliveryKarin Schoenhammer, Julie Boisclair, Helmut Schuetz, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of Drug Targeting|May 8, 2015
Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticlesRobert Hennig, Klaus Pollinger, Joerg Tessmar, et al.
International Journal of Pharmaceutics|November 17, 2015
HPLC analysis as a tool for assessing targeted liposome compositionMira Oswald, Michael Platscher, Simon Geissler, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryMiriam Breunig, Uta Lungwitz, Renate Liebl, et al.
Macromolecular Bioscience|February 21, 2020
The Effect of Ligand Mobility on the Cellular Interaction of Multivalent NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
Pharmaceutical Research|February 26, 2020
Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
Journal of Drug Targeting|March 15, 2016
Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosisRobert Hennig, Sabrina Kuespert, Alexandra Haunberger, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 29, 2017
Polyanion based controlled release system for the GnRH-receptor antagonist degarelixMichael Backofen, Gregoire Schwach, Wolfgang Koechling, et al.
Drug Discovery Today|June 2, 2022
Targeted drug delivery to the retinal pigment epithelium: Untapped therapeutic potential for retinal diseasesMarilena Bohley, Andrea E Dillinger, Ernst R Tamm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 17, 2014
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylationRobert Hennig, Klaus Pollinger, Anika Veser, et al.
Journal of Pharmaceutical Sciences|July 29, 2010
Biocompatibility of an injectable in situ forming depot for peptide deliveryKarin Schoenhammer, Julie Boisclair, Helmut Schuetz, et al.
Pageof 9